Template talk:Infobox drug: Difference between revisions
→Tolerance potential?: Reply |
→Edit request {{subst:#time:j F Y}}: new section |
||
Line 153: | Line 153: | ||
Thank you! [[User:Kiwiz1338|Kiwiz1338]] ([[User talk:Kiwiz1338|talk]]) 15:21, 3 October 2023 (UTC) |
Thank you! [[User:Kiwiz1338|Kiwiz1338]] ([[User talk:Kiwiz1338|talk]]) 15:21, 3 October 2023 (UTC) |
||
== Edit request 15 November 2023 == |
|||
{{Edit template-protected|answered=}} |
|||
'''Description of suggested change:''' |
|||
Edit the change I made to the legal_US= line into the template. I tested it in [[Template:Infobox drug/sandbox]] and it works. It will display [[Boxed warning|<math>\begin{array}{|} \hline W\!ARNING \\ \hline \end{array}</math>]]<ref name="FDA-AllBoxedWarnings">{{cite web |title=FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.) |url=https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802 |website=nctr-crs.fda.gov |publisher=[[FDA]] |access-date=22 Oct 2023}}</ref> based on data I've begun adding to wikidata. I have buy-in at |
|||
[[WT:MED#Black_box_warnings_project]]. |
|||
'''Diff:''' |
|||
{{TextDiff|1=|legal_US={{{legal_US|}}}|2=|legal_US={{#ifeq: {{#invoke:String|match|s={{#property:P3493}}|pattern=boxed warning|plain=true}}|boxed warning|[[Boxed warning|<math>\begin{array}{|} \hline W\!ARNING \\ \hline \end{array}</math>]]<ref name="FDA-AllBoxedWarnings">{{cite web |title=FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.) |url=https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802 |website=nctr-crs.fda.gov |publisher=[[FDA]] |access-date=22 Oct 2023}}</ref>}}{{{legal_US|}}} |
|||
}} (I entered the code as directed but it doesn't display properly in preview. If needed, view diff.) |
|||
[[User:RudolfoMD|RudolfoMD]] ([[User talk:RudolfoMD|talk]]) 01:05, 15 November 2023 (UTC) |
Revision as of 01:05, 15 November 2023
Template:Infobox drug is permanently protected from editing because it is a heavily used or highly visible template. Substantial changes should first be proposed and discussed here on this page. If the proposal is uncontroversial or has been discussed and is supported by consensus, editors may use {{edit template-protected}} to notify an administrator or template editor to make the requested edit. Usually, any contributor may edit the template's documentation to add usage notes or categories.
Any contributor may edit the template's sandbox. Functionality of the template can be checked using test cases. |
This is the talk page for discussing improvements to the Infobox drug template. |
|
Archives: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19Auto-archiving period: 90 days |
This template does not require a rating on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||
|
Infobox drug: Changes log
|
---|
|
Tolerance potential?
I’m sort of puzzled why things like addiction liability and dependence liability are a thing in these info boxes for various drugs but tolerance potential/rate isn’t? I know there is a number of variables like dosage and rate of frequency and even individual enzyme properties, or maybe even receptor sensitivity, but the same is also evidently true for the other aforementioned potentials. From what I can clearly tell, some substances certainly have abnormally fast tolerance increases (such as opioids & amphetamines); whereas others can have pretty modest rate of increased tolerance. And even substances with potential for reverse-tolerance (like salvia and cannabis) should also have this mentioned in the infobox. Dexedream (talk) 04:36, 10 May 2023 (UTC)
- Interesting thoughts. Got sources? FYI, I'm working on adding an indicator on pages for drugs that have black box warnings. I found a source database but I'm struggling to figure out the correct edits to the templates. (Template talk:Infobox drug/legal status/sandbox, and/or Template talk:Infobox drug/sandbox...) RudolfoMD (talk) 04:28, 23 October 2023 (UTC)
Legal status in Brazil - Add subclasses F1, F2 and F3
This edit request to Template:Infobox drug/legal status has been answered. Set the |answered= or |ans= parameter to no to reactivate your request. |
Keep the "Class F (Prohibited substances)" for backward compatibility, but add:
- Class F1 (Prohibited narcotics)
- Class F2 (Prohibited psychotropics)
- Class F3 (Prohibited precursors)
- Class F4 (Other prohibited substances)
There is also a specific list for antibiotics, but I'm thinking to just use the general "Rx-only" tag for that. I need to dig, search for more information and think how that could be classified here. But for now, just adding the F subclasses would be great. Thanks :) Arthurfragoso (talk) 20:12, 3 August 2023 (UTC)
- I would like the changes shown in this diff. — Arthurfragoso (talk) 17:41, 27 August 2023 (UTC)
- Completed. P.I. Ellsworth , ed. put'er there 23:52, 27 August 2023 (UTC)
Edit request 5 August 2023
This edit request to Template:Infobox drug/formatIUPHARBPS has been answered. Set the |answered= or |ans= parameter to no to reactivate your request. |
Description of suggested change:
Template:Infobox_drug/formatIUPHARBPS should use https
instead of http
.
- Completed. P.I. Ellsworth , ed. put'er there 20:15, 5 August 2023 (UTC)
Adding new countries to Legal Status
The main ones I would like to be added are: India, China and Russia. But clicking in the Category:Drugs with non-standard legal status and checking some, we may have to add South Korea (Olmutinib), Singapore(5-Benzyloxytryptamine), Sweden (Flualprazolam) and Japan (Delgocitinib, Tirabrutinib) at some point. Mexico would be another good one to add. Or we could just add the whole ISO 639-1 list of country codes. 😅
- Drug policy of India -> But the categories listed at Regulation of therapeutic goods#India (Schedule X, H, L, C, C1, N, M) - I found the Indian government document explaining each one the other day, I believe there is more categories than this, I will find it again and make a summary.
- Drug policy of South Korea - Not much explanation, but we could initially just add the general OTC, Rx, vet.
- Drug policy of Sweden - Schedule I to V
- Misuse of Drugs Act (Singapore) - Schedule I to III and subcategories
The easiest information available about Chinese drug regulation is the "OTC class A" (drugstores only) and "OTC class B" (also available in general stores).
It's too much to add information about the classification about each countries at once. I'm initially informing the intent, but I will dig and summarize about each one in more details later.
-- Arthurfragoso (talk) 21:17, 14 August 2023 (UTC)
- All the schedules in India are at: Drugs and Cosmetics Rules, 1945
- -- Arthurfragoso (talk) 05:59, 15 August 2023 (UTC)
Template-protected edit request on 3 September 2023
This edit request to Template:Infobox drug/licence has been answered. Set the |answered= or |ans= parameter to no to reactivate your request. |
The link to EMA pages is dead, and should most likely be replaced as follows;
From
EU EMA -->{{#ifeq:{{{licence_EU|}}} |yes| * <small>{{abbr|EU|European Union|class=country-name}}</small> [[European Medicines Agency|EMA]]: <span title="www.ema.europa.eu: '{{#invoke:String|replace|source={{{_EMA_use_INN|}}} |pattern=[%<%>]|replace=|plain=false}}' ">[http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword={{urlencode:{{#invoke:String|replace|source={{{_EMA_use_INN|}}} |pattern=(%w)%/(%w)|replace=%1 / %2|plain=false}} }} {{#if:{{{INN_EMA|}}} |by {{{INN_EMA|}}} |by INN}}]</span> }}<!--
To
EU EMA -->{{#ifeq:{{{licence_EU|}}} |yes| * <small>{{abbr|EU|European Union|class=country-name}}</small> [[European Medicines Agency|EMA]]: <span title="www.ema.europa.eu: '{{#invoke:String|replace|source={{{_EMA_use_INN|}}} |pattern=[%<%>]|replace=|plain=false}}' ">[https://www.ema.europa.eu/en/medicines/search_api_aggregation_ema_active_substance_and_inn_common_name/{{urlencode:{{#invoke:String|replace|source={{{_EMA_use_INN|}}} |pattern=(%w)%/(%w)|replace=%1 / %2|plain=false}} }} {{#if:{{{INN_EMA|}}} |by {{{INN_EMA|}}} |by INN}}]</span> }}<!--
This should ensure proper link references working, for EMA approvals. 62.83.128.242 (talk) 02:04, 3 September 2023 (UTC)
- Done For the record, the new links often don't work for me either, but they sometimes do and it's clearly better than the old completely-broken ones. * Pppery * it has begun... 21:42, 4 September 2023 (UTC)
Global Substance Registration System - GSRS
Please consider adding GSRS to the infobox.
The Global Ingredient Archival System provides a common identifier for all of the substances used in medicinal products, utilizing a consistent definition of substances globally, including active substances under clinical investigation, consistent with the ISO 11238 standard.
--Whywhenwhohow (talk) 18:00, 24 September 2023 (UTC)
Legal status in New Zealand
Hello, could you please add the following legal status for New Zealand please.
- Prescription
- Restricted
- Pharmacy only
- A - Class A
- B1 - Class B1
- B2 - Class B2
- B3 - Class B3
- C1 - Class C1
- C2 - Class C2
- C3 - Class C3
- C4 - Class C4
- C5 - Class C5
- C6 - Class C6
- C7 - Class C7
Please keep the following
- NZ: OTC
- NZ: Temporary Class
- NZ: Fourth Schedule
The Class A/B/C already in there can be replaced with my proposal
https://www.medsafe.govt.nz/profs/class/classintro.asp#top
Thank you! Kiwiz1338 (talk) 15:21, 3 October 2023 (UTC)
Edit request 15 November 2023
It is requested that an edit be made to the template-protected template at Template:Infobox drug. (edit · history · last · links · sandbox · edit sandbox · sandbox history · sandbox last edit · sandbox diff · test cases · transclusion count · protection log) This template must be followed by a complete and specific description of the request, so that an editor unfamiliar with the subject matter could complete the requested edit immediately.
Edit requests to template-protected pages should only be used for edits that are either uncontroversial or supported by consensus. If the proposed edit might be controversial, discuss it on the protected page's talk page before using this template. Consider making changes first to the template's sandbox and test them thoroughly here before submitting an edit request. To request that a page be protected or unprotected, make a protection request. When the request has been completed or denied, please add the |
Description of suggested change: Edit the change I made to the legal_US= line into the template. I tested it in Template:Infobox drug/sandbox and it works. It will display [1] based on data I've begun adding to wikidata. I have buy-in at WT:MED#Black_box_warnings_project.
Diff:
− | + |
(I entered the code as directed but it doesn't display properly in preview. If needed, view diff.)
RudolfoMD (talk) 01:05, 15 November 2023 (UTC)
- ^ "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 Oct 2023.
- Template-Class pharmacology articles
- NA-importance pharmacology articles
- WikiProject Pharmacology articles
- Template-Class medicine articles
- NA-importance medicine articles
- All WikiProject Medicine pages
- Template-Class chemicals articles
- NA-importance chemicals articles
- Wikipedia template-protected edit requests